SCHEMBL1005643

SCHEMBL1005643

Clc1ccccc1Br.[MgH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL251393 0.97
SCHEMBL29637350 0.97
Hydrochloric Acid SCHEMBL28201454 0.94
Ethylene SCHEMBL28840336 0.91 TSHR (0.50)
Methyl Alcohol SCHEMBL27865100 0.88 TSHR (0.47)
Hydrazine SCHEMBL28946830 0.88 TSHR (0.47)
Chlorobenzene SCHEMBL28111347 0.86 TSHR (0.58)
SCHEMBL28868561 0.86 TSHR (0.45)
SCHEMBL20495707 0.84 CA1 (0.44)
SCHEMBL27783827 0.84 LMNA (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102066002-B Original position olefin polymerization catalyst system PROMERUS, LLC (US) 2015-08-26 CN claimed
CN-102066002-A In situ olefin polymerization catalyst system PROMERUS LLC 2011-05-18 CN claimed
CN-117561251-A Modulators of TREX1 星座制药公司 2024-02-13 CN disclosed
US-20230159453-A1 INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION COCRYSTAL PHARMA, INC. 2023-05-25 US disclosed
EP-4132944-A1 INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION Cocrystal Pharma, Inc. (US) 2023-02-15 EP disclosed
CN-115698035-A Inhibitors of norovirus and coronavirus replication 共晶制药公司 2023-02-03 CN disclosed
CN-108884070-B Pyridyl derivatives as bromodomain inhibitors 葛兰素史克知识产权第二有限公司 2021-07-02 CN disclosed
US-10858366-B2 Tricyclic compounds useful to treat orthomyxovirus infections NOVARTIS AG (CH) 2020-12-08 US disclosed
EP-3526227-A1 BINUCLEAR METAL COMPLEXES AND ELECTRONIC DEVICES, IN PARTICULAR ORGANIC ELECTROLUMINESCENT DEVICES CONTAINING SAID METAL COMPLEXES Merck Patent GmbH (DE) 2019-08-21 EP disclosed
EP-3507294-A1 BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES Merck Patent GmbH (DE) 2019-07-10 EP disclosed
EP-3484868-A1 METAL COMPLEXES Merck Patent GmbH (DE) 2019-05-22 EP disclosed
EP-1902032-A1 PHARMACEUTICAL COMPOUNDS Astex Therapeutics Limited (GB) 2008-03-26 EP disclosed
WO-2006136821-A1 PHARMACEUTICAL COMPOUNDS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO disclosed
WO-2006136837-A2 PHARMACEUTICAL COMBINATIONS COMPRISING PYRAZOLE DERIVATIVES AS PROTEIN KINASE MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO disclosed
EP-1706385-A1 PYRAZOLE DERIVATIVES AS PROTEIN KINASE MODULATORS Astex Therapeutics Limited (GB) 2006-10-04 EP disclosed
WO-2005061463-A1 PYRAZOLE DERIVATIVES AS PROTEIN KINASE MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2005-07-07 WO disclosed
EP-0770078-A1 8-ARYL-1,6-NAPHTHYRIDIN-5-ONES F. HOFFMANN-LA ROCHE AG (CH) 1997-05-02 EP disclosed
US-5583000-A DETECTING PRESENCE OF RETROVIRAL PROTEASES IN SAMPLE BY COMBINING WITH SPECIFIED COMPOUND AND DETECTING PRESENCE OF COMPLEXES FORMED THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1996-12-10 US disclosed
WO-1996002541-A1 8-ARYL-1,6-NAPHTHYRIDIN-5-ONES F. HOFFMANN-LA ROCHE AG (CH) 1996-02-01 WO disclosed
US-5466697-A 8-phenyl-1,6-naphthyridin-5-ones SYNTEX (U.S.A.) INC. (US) 1995-11-14 US disclosed